SLC12A5 and cognitive disorder: In summary, our results highlight a mechanistic link between the expression of IL-1β/KCC2 and long-lasting cognitive impairment in a neonatal severe inflammation model and provide an underlying molecular target to prevent and/or treat cognitive disorders after early septic inflammation.